共 26 条
[1]
Antibiotics resistance rate of Helicobacter pylori in Bhutan[J]. Ratha-korn Vilaichone,Yoshio Yamaoka,Seiji Shiota,Thawee Ratanachu-ek,Lotay Tshering,Tomohisa Uchida,Toshio Fujioka,Varocha Mahachai.World Journal of Gastroenterology. 2013(33)
[4]
Treatment of H elicobacter pylori Infection 2013[J] . Anthony O’Connor,Javier Molina‐Infante,Javier P. Gisbert,Colm O’Morain.Helicobacter . 2013
[5]
Diagnosis and Epidemiology of H elicobacter pylori Infection[J] . Xavier Calvet,María‐José Ramírez Lázaro,Philippe Lehours,Francis Mégraud.Helicobacter . 2013
[6]
Efficacy of Bismuth-Containing Quadruple Therapies for Clarithromycin-, Metronidazole-, and Fluoroquinolone-Resistant Helicobacter pylori Infections in a Prospective Study[J] . Xiao Liang,Xiaoqing Xu,Qing Zheng,Wei Zhang,Qinjuan Sun,Wenzhong Liu,Shudong Xiao,Hong Lu.Clinical Gastroenterology and Hepatology . 2013 (7)
[8]
Su1706 Amoxicillin in Replacement for Bismuth Subcitrate Offers Similar Helicobacter pylori Eradiation Response in Second-Line Rabeprazole-Based Quadruple Therapy[J] . Huang-Ming Hu,Ping-I Hsu,Seng-Kee Chuah,Meng-Kwan Liu,Fu-Chen Kuo,Chao-Hung Kuo,Deng-Chyang Wu.Gastroenterology . 2012 (5)
[9]
Second‐line Helicobacter pylori Eradication: A Randomized Comparison of 1‐week or 2‐week Bismuth‐containing Quadruple Therapy[J] . Jun‐WonChung,Jeong HoonLee,Hwoon‐YongJung,Sung‐CheolYun,Tae‐HoonOh,Kee DonChoi,Ho JuneSong,Gin HyugLee,Jin‐HoKim.Helicobacter . 2011 (4)